You are here

P&T® Journal contents for September 2006

Features

The authors review the increased incidence of antibiotic-associated diarrhea as well as its pathogenesis, diagnosis, prevention, and treatment.
April D. Miller, PharmD, Kelly M. Smith, PharmD, P. Shane Winstead, PharmD, and Craig A. Martin, PharmD
P&T Around the World
A mysterious illness in several Vietnamese children sets off an investigation that has worldwide implications for vaccine supply chains and safe handling practices.
Peter G. Teichman, MD, MPA, and Nguyen Tri Doan, MD
Epoetin alpha (recombinant human erythropoietin) is effective for anemia in patients with chronic kidney disease or cancer, but not all patients respond favorably. The authors sought to predict which patients would be likely to respond before therapy is begun.
Justin Welch, PharmD, BCPS, Matthew Webb, PharmD, Ji Koo, PharmD, and Curt Doetkott, MS
The author explores the interrelationships of calcium, vitamin D, and phenytoin and their effects on bone health in patients with epilepsy.
Alexander Motylev, RPh, PhD
Meeting Highlights
Cancer progress and a vaccine for vaginal/vulvar cancers are reviewed.
Lawrence M. Prescott, PhD, and Sharon L. Prescott
Dasatinib (Sprycel), bevacizumab plus IV 5-fluorouracil (Avastin), and topotecan injection (Hycamptin) plus cisplatin are discussed.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial
David Nash, MD, MBA, discusses the Sheffield Teaching Hospitals NHS Foundation Trust and its goal of implementing rational drug therapy in Britain.
David Nash, MD, MBA
Medication Errors
Matthew Grissinger, RPh, FASCP, explains how double-checks by a second person can reduce discrepancies and errors in drug prescriptions and specialized regimens for high-risk patients.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Stephen Barlas takes another look at the Institute of Medicine’s 1999 report, To Err Is Human, and the lack of progress made in reducing medical errors since then.
Stephen Barlas
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Olga Hilas, PharmD, and Lisa Charneski, PharmD, review Fluarix influenza virus vaccine.
Olga Hilas, PharmD, BCPS, and Lisa Charneski, PharmD, BCPS